How different cycling training loads change gut bacteria, butyrate, fitness, and overreaching in healthy men

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

ICARUS is a randomized, controlled, three-arm trial that will enroll 45 healthy recreational men who will be assigned to a non-training control group, an eight-week supervised moderate-load cycling program, or an eight-week supervised high-load cycling program followed by a 10-day taper. The trial's primary focus is on gut microbial short-chain fatty acid production, especially butyrate, measured in blood and feces at four time points (baseline, 4 weeks, 8 weeks, and after taper). Researchers will also collect data on exercise performance, muscle phenotype, gut barrier integrity, and clinical markers of overreaching to link microbiome changes with physiological adaptations or maladaptations. Training is supervised in person at KU Leuven with standardized protocols and stratified randomization by baseline training volume.

Why it matters

Who can join: the full rules

Inclusion criteria:

* Males between 18 and 45 years old.
* Recreationally active individuals, with a weekly exercise training volume between one and six hours per week.
* Good health status confirmed by a sport medical screening, which includes a sport medical questionnaire and resting electrocardiogram.
* Body Mass Index (BMI) between 18.5 and 27.5 kg/m².
* Masters the Dutch language.

Exclusion criteria:

* Engagement in strenuous competitive sports one month prior to or during the study intervention.
* Medication and vaccination: Pro- or antibiotic treatment during the past three months, non-steroidal anti-inflammatory drugs (NSAIDs) or cholestyramine during the past month, drugs interfering with intestinal permeability (e.g., prokinetics, laxatives, lubiprostone, loperamide, anti-spasmodics, linaclotide, proton pump inhibitors) during the past month. Vaccinations within one month prior to or during the study intervention.
* Blood donations within three months or plasma donation within one month prior to or during the study intervention.
* Inflammatory bowel disease (Crohn or colitis ulcerosa) or celiac disease.
* Diagnosed irritable bowel syndrome.
* Intake of any performance-enhancing medication or nutritional supplements known to modulate the gut microbiome in the two months prior to or during the study.
* Substance abuse, including alcohol consumption of more than three units/day (weekly average).
* Any injury or pathology considered a contraindication for performing physical exercise, as determined by the medical doctor overseeing the preparticipation medical screening.
* No access to smartphone and/or computer with internet access.
* No willingness to use the Polar Flow app and MijnEetmeter to collect physical activity, heart rate, sleep, and food intake data.
* Concomitant participation in another interventional trial, without approval from the research team.
* Any other reasons considered by the research team that the participant will not complete the study.

Where it's running

• Exercise Physiology Research Group, Department of Movement Sciences, KU Leuven, Leuven, Belgium
  Leuven, Vlaams Brabant, Belgium Recruiting

Study contacts

• Principal investigator: Stefan De Smet, Professor — Exercise and Muscle Physiology Research Group, Department of Movement Sciences, KU Leuven, Leuven, Belgium
• Study coordinator: Stefan De Smet
• Email: stefan.desmet@kuleuven.be
• Phone: +32 16 37 64 87

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• How expected meal availability changes eating and decision-making in young women

  This study will test whether knowing when a meal will be available changes how healthy, naturally cycling women respond to food cues, feel, and how much they eat.

  Recruiting German Institute of Human Nutrition · Nuthetal, Brandenburg · NCT07133529

• A large-scale digital health study using Apple devices

  This study is trying to see how data from Apple devices can help us understand and manage different health issues like mental health, sleep, and exercise for a wide range of people.

  Recruiting at 2 sites Apple Inc. · Washington D.C., District of Columbia and 1 other locations · NCT06958523

• Home-based exercise program for kidney transplant recipients

  This study is testing whether a home-based exercise program can help kidney transplant recipients improve their fitness and overall health compared to different levels of exercise intensity.

  Recruiting at 2 sites KU Leuven · Ghent and 1 other locations · NCT06260579

• Bringing preventive cardiovascular care to Indigenous and remote communities

  This project tests a mobile health unit to screen and provide culturally safe cardiovascular and metabolic care for Indigenous and remote communities in Canada.

  Recruiting Laval University · Québec, Quebec · NCT07869069

• Resveratrol and Estrogen Receptors in Postmenopausal Women with CAD

  This study tests whether taking resveratrol is safe and can change estrogen-related markers in postmenopausal women with coronary artery disease.

  Recruiting InCor Heart Institute · São Paulo, São Paulo · NCT07865377

• Overnight Temperature Regulation to Test Gut Health, Inflammation, and Circadian Rhythms

  This study tests whether two weeks of using the Eight Sleep Pod at night can improve gut bacteria balance, lower inflammation, and strengthen daily temperature and blood pressure rhythms in postmenopausal women and age-matched men with poor sleep.

  Recruiting Eight Sleep Inc. · Newton Center, Massachusetts · NCT07848594

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.